Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy

About 70–80% of early breast cancer (BC) patients receive adjuvant endocrine therapy (ET) for at least 5 years. ET includes in the majority of cases the use of aromatase inhibitors, as upfront or switch strategy, that lead to impaired bone health. Given the high incidence and also the high prevalenc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Treat Options Oncol
Main Authors: Diana, Anna, Carlino, Francesca, Giunta, Emilio Francesco, Franzese, Elisena, Guerrera, Luigi Pio, Di Lauro, Vincenzo, Ciardiello, Fortunato, Daniele, Bruno, Orditura, Michele
Format: Artigo
Sprog:Inglês
Udgivet: Springer US 2021
Fag:
Breast Cancer (WJ Gradishar, Section Editor)
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8052225/
https://ncbi.nlm.nih.gov/pubmed/33864145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-021-00835-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker